We found 117 records for "Licensing / acquisition"

Articles

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

UCB looks ahead to next phase

2nd June 2014

 UCB looks ahead to next phaseArticles

As UCB marks 10 years in the UK with a special event at its research centre in Slough, Andrew McConaghie talks to chief executive Roch Doliveux about the company's future.Ten...

Read more

European M&A in the Lifesciences sector: 2013 and beyond

7th April 2014

 European M&A in the Lifesciences sector: 2013 and beyondArticles

Sandra Rafferty of CMS London explores European M&A activity in the Lifesciences sector in 2013 and looks ahead to what 2014 might hold.2013: OverviewAlthough general M&A activity levels in Europe...

Read more

A history of Shire

3rd December 2013

 A history of ShireArticles

pharmaphorum's Hannah Blake looks into the history of one of the world's fastest growing specialty pharmaceutical companies, Shire, to find out how, only twenty-seven years after creation, it has become...

Read more

News

AbbVie and Shire merger agreed

21st July 2014

 AbbVie and Shire merger agreedNews

AbbVie and Shire have announced that their long-awaited merger is to go ahead, following AbbVie's fifth takeover offer.The deal, which the companies announced on Friday, is worth £32 billion ($53 billion).  The...

Read more

Sterile injectables growth tempts Pfizer into $360m InnoPharma acquisition

17th July 2014

 Sterile injectables growth tempts Pfizer into $360m InnoPharma acquisitionNews

Pfizer has increased its position in the $7 billion-plus market for sterile injectable drugs with a $360 million agreement to buy New Jersey-based InnoPharma.The US pharma giant wants a bigger...

Read more

US lawmakers aim to block tax inversion deals

16th July 2014

 US lawmakers aim to block tax inversion dealsNews

US companies could be blocked from reducing their corporate tax liabilities by merging with overseas companies - a process known as tax inversion - if President Obama has his way.The...

Read more

Shire enters takeover talks with AbbVie

14th July 2014

 Shire enters takeover talks with AbbVieNews

Shire has started 'detailed discussions' with AbbVie over a possible takeover after receiving a revised offer valuing its business at more than £31bn ($53bn).The latest £53.20 per share offer is...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Events

MAGHREB PHARMA Expo 2014

20th September 2014 - 22nd September 2014

MAGHREB PHARMA Expo 2014

MAGHREB PHARMA Expo is the Largest Pharma Technology tradeshow in Africa. With more than 150 international exhibitors providing APIs, Equipments, Machinery, Cleanroom, Packaging, Engineering and all related services, this...

Read more

Payers' Forum Europe

1st October 2014 - 2nd October 2014

Payers' Forum Europe

This is the event to ensure your product’s access and to ensure its reimbursed and at the best price. Speaking at the event, we have the top payers from NHS,...

Read more

20th annual European Pharmaceutical Pricing and Reimbursement

13th October 2014 - 14th October 2014

20th annual European Pharmaceutical Pricing and Reimbursement

Market access remains one of the most significant current and future challenges for the industry. Spiralling drug development costs exert pressure to ensure successful and effective planning of your access...

Read more

2nd International Congress on Paragraph IV Litigation Strategy

29th October 2014 - 30th October 2014

2nd International Congress on Paragraph IV Litigation Strategy

Successful IP Litigation Strategies for Brand Name and Generic Manufacturers Imminent blockbuster patent expiration…new regulatory hurdles and procedural requirements created by the Biologics Price Competition and Innovation and America Invents Act…constantly...

Read more